CZEREPAK ELIZABETH
Transactions
22
Companies
9
Filings
16
CIK
0001263500
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Conversion
- Conversion
- Award
Companies
9AFFYMAX INC
Director, 10% Owner
- $ALT
Altimmune, Inc.
CFO and EVP Corp. Development
- $DCTH
DELCATH SYSTEMS, INC.
Director
MiddleBrook Pharmaceuticals, Inc.
Director
- $SCLX
Scilex Holding Co
See Remarks
Sorrento Therapeutics, Inc.
Director
SPECTRUM PHARMACEUTICALS INC
Director
- $RNAZ
Transcode Therapeutics, Inc.
Director
Vyant Bio, Inc.
Chief Financial Officer
Recent Filings
16- 4
CZEREPAK ELIZABETH
May 19, 2025
- 4
CZEREPAK ELIZABETH
May 28, 2024
- 4
CZEREPAK ELIZABETH
Jun 21, 2023
- 4
CZEREPAK ELIZABETH
Jan 17, 2023
- 4
CZEREPAK ELIZABETH
May 20, 2022
- 4
CZEREPAK ELIZABETH
May 6, 2022
- 4
CZEREPAK ELIZABETH
Nov 18, 2021
- 4
CZEREPAK ELIZABETH
Aug 9, 2021
- 4
CZEREPAK ELIZABETH
Nov 25, 2020
- 4
CZEREPAK ELIZABETH
Jun 19, 2020
- 4
CZEREPAK ELIZABETH
Jul 2, 2019
- 4
CZEREPAK ELIZABETH
Sep 26, 2017
- 4
Altimmune, Inc.
May 8, 2017
- 4
AFFYMAX INC
May 31, 2007
- 4
ADVANCIS PHARMACEUTICAL CORP
May 26, 2005
- 4
ADVANCIS PHARMACEUTICAL CORP
Oct 24, 2003
Address
201 ROUTE 17 NORTH 2ND FLOOR
RUTHERFORD, NJ, 07070